InsiderClue
Insiders · Profile

Easom Eric

Chief Executive Officer at AN2 Therapeutics. Filing since 20 Oct 2022. CIK 0001914503

Company
Date
Role
Action
Shares
Amount
Of holding
ANTX AN2 Therapeutics, Inc.
2 Jun 2025
Chief Executive Officer
Bought
10,000
$10.67K
4.1%
ANTX AN2 Therapeutics, Inc.
18 Nov 2024
Chief Executive Officer
Bought
50,000
$49.97K
4.9%
ANTX AN2 Therapeutics, Inc.
2 Jan 2024
Chief Executive Officer
Sold on a plan
2,777
$55.80K
56.6%
ANTX AN2 Therapeutics, Inc.
15 May 2023
Chief Executive Officer
Bought
10,000
$53.77K
1.0%
ANTX AN2 Therapeutics, Inc.
14 Nov 2022
Chief Executive Officer
Sold, plan not stated
23
$345.92
0.5%
ANTX AN2 Therapeutics, Inc.
10 Nov 2022
Chief Executive Officer
Sold, plan not stated
4,413
$67.63K
47.2%
ANTX AN2 Therapeutics, Inc.
9 Nov 2022
Chief Executive Officer
Sold, plan not stated
10,111
$157.85K
67.3%
ANTX AN2 Therapeutics, Inc.
8 Nov 2022
Chief Executive Officer
Sold, plan not stated
7,055
$109.95K
32.0%
ANTX AN2 Therapeutics, Inc.
7 Nov 2022
Chief Executive Officer
Sold, plan not stated
12,203
$195.74K
71.3%
ANTX AN2 Therapeutics, Inc.
4 Nov 2022
Chief Executive Officer
Sold, plan not stated
8,828
$139.47K
34.0%
ANTX AN2 Therapeutics, Inc.
3 Nov 2022
Chief Executive Officer
Sold, plan not stated
14,165
$223.06K
35.3%
ANTX AN2 Therapeutics, Inc.
2 Nov 2022
Chief Executive Officer
Sold, plan not stated
1,544
$23.26K
23.9%
ANTX AN2 Therapeutics, Inc.
31 Oct 2022
Chief Executive Officer
Sold, plan not stated
2,688
$41.36K
29.4%
ANTX AN2 Therapeutics, Inc.
28 Oct 2022
Chief Executive Officer
Sold, plan not stated
1,683
$25.39K
25.5%
ANTX AN2 Therapeutics, Inc.
27 Oct 2022
Chief Executive Officer
Sold, plan not stated
924
$14.19K
12.3%
ANTX AN2 Therapeutics, Inc.
26 Oct 2022
Chief Executive Officer
Sold, plan not stated
1,678
$25.34K
25.5%
ANTX AN2 Therapeutics, Inc.
25 Oct 2022
Chief Executive Officer
Sold, plan not stated
4,806
$75.67K
42.2%
ANTX AN2 Therapeutics, Inc.
24 Oct 2022
Chief Executive Officer
Sold, plan not stated
2,866
$46.34K
20.1%
ANTX AN2 Therapeutics, Inc.
21 Oct 2022
Chief Executive Officer
Sold, plan not stated
13,951
$228.24K
74.0%
ANTX AN2 Therapeutics, Inc.
20 Oct 2022
Chief Executive Officer
Sold, plan not stated
7,293
$121.67K
27.9%
20 decisions on file.